For successful clinical trials today, it’s necessary to go global. But challenges still abound
Feat. The challenges of global clinical trials; Trump takes on big pharma; the best UK pharma tweeters
The former president of AstraZeneca UK and the ABPI has given up big pharma to join biotech Redx. We speak to her about what prompted the change, how she thinks British life science will fare in the coming years, and how the UK can help smaller companies like Redx to thrive
A new report looks at the effectiveness of dedicated UK twitter accounts for pharma companies
New from PharmaTimes Media is the Medical & Scientific Excellence Awards.Highlighting this important area of work within the pharmaceutical industry, the awards are designed to recognise the outstanding achievements of medical and scientific professionals.
21st September 2018
Bedrock, DDB Remedy and Insypher lead the agency field, Gilead tops the pharma chart
21st September 2018
The Association of the British Pharmaceutical Industry (ABPI) is linking arms with the Academic Health Science Network in a five-year partnership that strives to accelerate uptake of transformative biomedical innovations by the NHS
21st September 2018
Celgene has decided not to exercise its option to license OncoMed's bispecific antibody navicixizumab.
21st September 2018
Daiichi Sankyo has entered into a clinical trial collaboration agreement with a subsidiary of MSD to evaluate a potential new combination therapy for breast or lung cancers.
21st September 2018
A fully digital NHS should be close to reality, but it’s a challenge that many hospitals are not ready to take on
Five steps to overcome challenges presented in pharmaceutical sales
In today’s trade environment, efficient screening is virtually impossible without IT support
Why current immigration plans are not adequette to deal with the growing crisis
The industry vet and current company group chairman of Janssen EMEA gives his views on the past, present and future of the pharma industry
Derek Elston, trustee of the ITP Support Association, tells PharmaTimes about his experiences of being diagnosed and living with the rare bleeding disorder
A new report looks at the effectiveness of dedicated UK twitter accounts for pharma companies
Longer-term budgeting and integrated care systems could transform the NHS’ approach to medicines
The president's FDA commissioner could become a “Scrooge” for the industry
The CMA has tackled some major pharma cases since its inception, but recent events leave question marks over its future approach
Despite the excitement surrounding T-cell therapy, CAR-T cells have fallen short in effectiveness against solid tumours. Oxfordshire-based Adaptimmune is one of the companies exploring T-cell receptors as a promising alternative. We spoke to the company’s chief technology officer Gwen Binder-Scholl about the science behind this challenging but exciting therapeutic area
For successful clinical trials today, it’s necessary to go global. But challenges still abound
It’s an exciting time to be working in the industry; with this comes new opportunities to collaborate and drive innovation
Inceptua’s Edoardo Madussi shares his insights on how to overcome the challenges of multi-country clinical trials
The implementation of risk-based monitoring is moving forward, but it is not without its challenges
The hard work to support the NHS in adopting biosimilars is not yet complete
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
